Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo
Open Access
- 22 July 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (44) , 76458-76467
Abstract
Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivoKeywords
This publication has 28 references indexed in Scilit:
- Synergism between Inositol Polyphosphates and TOR Kinase Signaling in Nutrient Sensing, Growth Control, and Lipid Metabolism in ChlamydomonasThe Plant Cell, 2016
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancerOncogene, 2015
- Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour developmentThe Journal of Pathology, 2015
- Clinicopathological significance of ASC amino acid transporter‐2 expression in pancreatic ductal carcinomaHistopathology, 2014
- Targeting glutamine transport to suppress melanoma cell growthInternational Journal of Cancer, 2014
- Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaBlood, 2013
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- Glutaminolysis Activates Rag-mTORC1 SignalingMolecular Cell, 2012
- Nγ-Aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding siteBioorganic & Medicinal Chemistry, 2005
- The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspectsPflügers Archiv - European Journal of Physiology, 2004